Christopher Tompkins
Chief Tech/Sci/R&D Officer at KromaTid, Inc.
Profile
Christopher Tompkins is currently the Chief Technology Officer at KromaTid, Inc. He previously worked as the Vice President-Operations at Eveia Medical, Inc. He holds a doctorate degree from North Carolina State University and an undergraduate degree from the University of Michigan, which he obtained in 1987.
Christopher Tompkins active positions
Companies | Position | Start |
---|---|---|
KromaTid, Inc.
KromaTid, Inc. Pharmaceuticals: MajorHealth Technology KromaTid, Inc. provides products and services for mutation detection and disease diagnosis. Its services include high resolution screening of individual genes to the entire genome, sequence, location and orientation from a single assay, cost effective discovery of inversions and translocations, rapid assay development and data delivery. The company was founded by Andrew F. Ray, Susan M. Bailey, Michael Cornforth, Edwin Goodwin, and Joel S. Bedford in 2007 and is headquartered in Longmont, CO. | Chief Tech/Sci/R&D Officer | 2009-12-31 |
Former positions of Christopher Tompkins
Companies | Position | End |
---|---|---|
Eveia Medical, Inc.
Eveia Medical, Inc. Medical/Nursing ServicesHealth Services Eveia Medical, Inc. provides medical and research diagnostics services. The firm’s product is the EVEIA bioanalytical system. Its product includes instrumentation, software, and the consumables required for automated analyte measurement and disease state identification. The company is headquartered in Boulder, CO. | Chief Operating Officer | - |
Training of Christopher Tompkins
University of Michigan | Undergraduate Degree |
North Carolina State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Eveia Medical, Inc.
Eveia Medical, Inc. Medical/Nursing ServicesHealth Services Eveia Medical, Inc. provides medical and research diagnostics services. The firm’s product is the EVEIA bioanalytical system. Its product includes instrumentation, software, and the consumables required for automated analyte measurement and disease state identification. The company is headquartered in Boulder, CO. | Health Services |
KromaTid, Inc.
KromaTid, Inc. Pharmaceuticals: MajorHealth Technology KromaTid, Inc. provides products and services for mutation detection and disease diagnosis. Its services include high resolution screening of individual genes to the entire genome, sequence, location and orientation from a single assay, cost effective discovery of inversions and translocations, rapid assay development and data delivery. The company was founded by Andrew F. Ray, Susan M. Bailey, Michael Cornforth, Edwin Goodwin, and Joel S. Bedford in 2007 and is headquartered in Longmont, CO. | Health Technology |
- Stock Market
- Insiders
- Christopher Tompkins